Prof. Hareth Nahi is a specialist in internal medicine and hematology, and has held the position of senior consultant in the Department of Hematology at the Karolinska University Hospital, Stockholm, Sweden since 2003. He is also Associate Professor in Hematology and Group Leader at the Center for Hematology and Regenerative Medicine (HERM) at the Dept of Medicine Huddinge, Karolinska Institutet since 2009, the research program focuses on cytogenetic and therapeutic mechanisms in multiple myeloma.
Dr Nahi has been Chair of the Nordic Myeloma Study Group (NMSG) from November 2015 to present. His other academic distinctions and merits include being a Member of the scientific committee at Black Swan Research initiative (BSRI).
Past appointments include Guest Editor for Lancet Oncology, Consultant for Cell Protect (cancer immunotherapy company) and Co-founder of Vycellix and Cell Protect. Dr Nahi is an author and co-author of more than 80 peer-reviewed publications and has participated in many clinical trials focusing on multiple myeloma but also involving patients with AML and lymphomas.